Adding to the data on non hypotensive shock in intermediate risk patients. Our latest publication on non invasive measure of cardiac index. Complements the CPES score. Glenn Fishman PERT Consortium Jay Giri Eric Secemsky MD MSc Rachel Rosovsky

#imagefirst A little pop quiz with IVUS. What is the structure seen outside of the prox LCA at 6 o’clock called?

Spot on as always Richard Sohn MD

Chronological vs Biological Age inInterventional Cardiology - A Comprehensive Approach to Care for Older Adults: JACC Family Series JACC Journals Mohamad Alkhouli

🥸We study 'older' patients undergoing percutaneous procedures. Older is not only 'number'.

😱Summary

👇👇👇

Should be a fun night of all things #ATO Dr Shariq Shamim Evandro Martins F. MD

My TCTMD video around the The PREVENT Trial with Ziad Ali and J Dawn Abbott
➡️tctmd.com/videos/beyond-…

➡️Could we not achieve similar results with PCSK9i?
➡️ Should be treat vulnerable plaques with PCI now based on this trial?

#CoronaryWirePerforation ?

#OTWballoon up in the branch for 5 min x1 or 2 -> still bleeding?

No need to rush with coiling->
#PlugAndSeal :
OTW balloon up and deploy #coils through the balloon

jacc.org/doi/epdf/10.10…

Evandro Martins F. MD Vladimir Lakhter Alex Truesdell Timir Paul, MD, PhD, FACC, FSCAI, FAHA

Happy Eid to all celebrating today! Easy on the cookies 😂

Second Prospective Randomized Control Trial Demonstrating the Benefit of Peripheral IVUS! 237 patients with fempop disease randomized to IVUS-guided DCB treatment vs angio-guided DCB treatment. 14% improvement in patency at 1 year, aligned with results from prior 150 person

Paradigm shifting study! Look-forward to future evidence to drive prophylactic treatment of vulnerable plaques and excited for the SpectraWAVE DeepOCT-NIRS platform to allow for simple identification of high-risk plaques!

Will Beaty The harms/risks of omission are usually attributed to the underlying HF disease state, failure of the meds that were prescribed, or the patient being non-adherent

Rarely considered as the result of no/delayed Rx

Yet, any symptom/AE frequently attributed to the meds started

The pathophysiology of post MI CAD with global “pan-coronaritis” is different than stable disease. Hence the results are not surprising! Stick to #complete nejm.org/doi/full/10.10…

Big win for #imagfirst ! Anatomy and physiology are complimentary! 🥂James Torey PA-C Ziad Ali Optima Education Glad we were always ahead of the curve.

Results also quite sobering, with a very high mortality rate in both arms. Leaves open the possibility that future device innovations to make MCS devices smaller, (fewer vascular and limb issues), have less hemolysis, or more stable positioning could further reduce rates of death

Lot of patients are going to be pleased about this. nejm.org/doi/full/10.10…

#dcsi #ncsi William W. O'Neill Babar Basir Amir Kaki, MD

Detroit led the way! #vindicated

Does anyone know how to get the benchtop Japanese PCI trainer? Need it for teaching lessons and testing a few bifurcation ideas…

Critical point. What works chronically might not have benefit acutely. Enough burdening patients with more drugs that wont' be covered/can't afford unless absolutely needed.

Catheter based therapies in intermediate or high risk PE— associated with lower mortality and readmission. RCTs eagerly awaited. Glenn Fishman NYU Langone Health Jay Giri Sahil A. Parikh, MD Catalin Toma, MD Sanjum S. Sethi MD, MPH Andrew SP Sharp PERT Consortium